Subscribe To Our Free Newsletter |
Zydus receives USFDA tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil and Chlorthalidone Tablets, 40 mg/12.5 mg and 40 mg/25 mg (USRLD: Edarbyclor tablets).